{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:04:51Z","timestamp":1783400691158,"version":"3.54.6"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jinf.2014.08.010","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T15:56:14Z","timestamp":1409414174000},"page":"44-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Experience with linezolid for the treatment of nocardiosis in organ transplant recipients"],"prefix":"10.1016","volume":"70","author":[{"given":"Oveimar","family":"De La Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucio R.","family":"Minces","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda P.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2014.08.010_bib1","series-title":"Principles and practices of infectious diseases","first-page":"3199","article-title":"Nocardia species","author":"Sorrell","year":"2009"},{"issue":"2","key":"10.1016\/j.jinf.2014.08.010_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s15010-009-9193-9","article-title":"Nocardiosis: updated clinical review and experience at a tertiary center","volume":"38","author":"Ambrosioni","year":"2010","journal-title":"Infection"},{"key":"10.1016\/j.jinf.2014.08.010_bib3","series-title":"Transplant infections","first-page":"295","article-title":"Other bacterial infections after hematopoietic stem cell or solid organ transplantation","author":"Djan","year":"2010"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.010_bib4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1001\/archinte.1979.03630400071025","article-title":"Failure of trimethoprim\/sulfamethoxazole in invasive Nocardia asteroides infection","volume":"139","author":"Geiseler","year":"1979","journal-title":"Arch Intern Med"},{"issue":"10","key":"10.1016\/j.jinf.2014.08.010_bib5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1086\/514340","article-title":"Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study","volume":"44","author":"Peleg","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.jinf.2014.08.010_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/clinids\/4.2.315","article-title":"Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia","volume":"4","author":"Wallace","year":"1982","journal-title":"Rev Infect Dis"},{"issue":"Suppl. 4","key":"10.1016\/j.jinf.2014.08.010_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/ajt.12102","article-title":"Nocardia infections in solid organ transplantation","volume":"13","author":"Clark","year":"2013","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.jinf.2014.08.010_bib8","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1128\/AAC.45.4.1295-1297.2001","article-title":"In\u00a0vitro activities of linezolid against multiple Nocardia species","volume":"45","author":"Brown-Elliott","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"issue":"9297","key":"10.1016\/j.jinf.2014.08.010_bib9","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(01)06964-1","article-title":"Oxazolidinone antibiotics","volume":"358","author":"Diekema","year":"2001","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.jinf.2014.08.010_bib10","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1345\/aph.1K196","article-title":"Linezolid for the treatment of Nocardia spp. infections","volume":"41","author":"Jodlowski","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"3","key":"10.1016\/j.jinf.2014.08.010_bib11","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1086\/345907","article-title":"Clinical experience with linezolid for the treatment of nocardia infection","volume":"36","author":"Moylett","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2014.08.010_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1093\/clinids\/22.6.891","article-title":"Nocardiosis","volume":"22","author":"Lerner","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.jinf.2014.08.010_bib13","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2014.08.010_bib14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1399-3062.2010.00588.x","article-title":"In\u00a0vitro activity of multiple antibiotic combinations against Nocardia: relationship with a short-term treatment strategy in heart transplant recipients with pulmonary nocardiosis","volume":"13","author":"Tripodi","year":"2011","journal-title":"Transpl Infect Dis"},{"issue":"6","key":"10.1016\/j.jinf.2014.08.010_bib15","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1128\/AAC.13.6.1042","article-title":"Cerebrospinal fluid penetration of amikacin","volume":"13","author":"Briedis","year":"1978","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.jinf.2014.08.010_bib16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1345\/aph.1H307","article-title":"Linezolid for the treatment of patients with central nervous system infection","volume":"41","author":"Ntziora","year":"2007","journal-title":"Ann Pharmacother"},{"issue":"7","key":"10.1016\/j.jinf.2014.08.010_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1468-1331.2005.01001.x","article-title":"Clinical experience with linezolid for the treatment of central nervous system infections","volume":"12","author":"Rupprecht","year":"2005","journal-title":"Eur J Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.jinf.2014.08.010_bib18","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0163-4453(09)60009-8","article-title":"Linezolid: a review of safety and tolerability","volume":"59","author":"Vinh","year":"2009","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jinf.2014.08.010_bib19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/BCR.0b013e3181c89ee3","article-title":"Potential subtherapeutic linezolid and meropenem antibiotic concentrations in a patient with severe burns and sepsis","volume":"31","author":"Hallam","year":"2010","journal-title":"J Burn Care Res"},{"issue":"8","key":"10.1016\/j.jinf.2014.08.010_bib20","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/jac\/dks153","article-title":"Therapeutic drug monitoring may improve safety outcomes of long-term treatment with linezolid in adult patients","volume":"67","author":"Pea","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.jinf.2014.08.010_bib21","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1128\/AAC.00177-10","article-title":"Therapeutic drug monitoring of linezolid: a retrospective monocentric analysis","volume":"54","author":"Pea","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445314002709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445314002709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:19:57Z","timestamp":1759007997000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445314002709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S0163445314002709"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2014.08.010","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Experience with linezolid for the treatment of nocardiosis in organ transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2014.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}